1. Home
  2. LIF vs CRSP Comparison

LIF vs CRSP Comparison

Compare LIF & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$67.32

Market Cap

5.5B

Sector

N/A

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.77

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIF
CRSP
Founded
2008
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
LIF
CRSP
Price
$67.32
$56.77
Analyst Decision
Strong Buy
Buy
Analyst Count
7
19
Target Price
$85.86
$71.50
AVG Volume (30 Days)
909.1K
2.2M
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$459,031,000.00
$38,337,000.00
Revenue This Year
$30.96
N/A
Revenue Next Year
$28.15
$723.84
P/E Ratio
$183.32
N/A
Revenue Growth
33.86
N/A
52 Week Low
$29.62
$30.04
52 Week High
$112.54
$78.48

Technical Indicators

Market Signals
Indicator
LIF
CRSP
Relative Strength Index (RSI) 32.51 51.01
Support Level $71.87 $54.41
Resistance Level $79.02 $59.25
Average True Range (ATR) 2.82 2.92
MACD -0.06 0.87
Stochastic Oscillator 0.23 71.31

Price Performance

Historical Comparison
LIF
CRSP

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: